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de histopatoloǵıa
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Abstract
The inter and intra subject variability is a common problem in several tasks associated to
the examination of histopathological samples. This variability might hinder the evaluation
of cancerous diseases. The development of automatic image analysis techniques and com-
puterized aided diagnostic tools in pathology aims to reduce the impact of such variability
by offering quantitative measurements and estimations. These measurements allow an accu-
rate evaluation and classification of the diseases in virtual slide images. The main problem
addressed in this thesis is evaluating the correlation of the automated identification of pat-
hological markers with cancer malignancy and aggresivenes. Hence, a set of classifier models
are trained to detect known pathological patterns. The classifiers are then used to quantify
the presence of the pathological markers. Finally, the resulting measurements are correla-
ted with the cancer risk recurrence. Results show that the automated detectors are able to
quantify patterns that show differences across several cancer risk groups.
Keywords: Histopathology, Digital pathology, Pathological marker
Resumen
La variabilidad inter e intra sujeto es un problema frecuente en muchas tareas asociadas al
exámen de muestras histopatológicas. Esta variabilidad puede incidir negativamente en la
evaluación de patoloǵıas relacionadas con el cáncer. El desarrollo de técnicas para el análisis
automático de imágenes y de herramientas de soporte al diagnóstico en patoloǵıa tiene como
objetivo reducir el impacto de la variabilidad inter/intra sujeto mediante la obtención de
medidas y estimaciones cuantitativas. Estas medidas permiten una evaluación y clasificación
más precisa de las enfermedades observables en láminas virtuales. El principal problema
abordado en esta tesis consiste en evaluar la correlación de la identificación automática de
marcadores patológicos con la agresividad del cancer. Aśı, un conjunto de clasificadores son
entrenados para detectar marcadores patológicos conocidos. Los clasificadores son posterior-
mente usados para cuantificar la presencia de los marcadores patológicos. Finalmente, las
mediciones resultantes son correlacionadas con el riesgo de recurrencia del cáncer. Los resul-
tados muestran que los detectores automáticos son capaces de cuantificar los patrones que
muestran diferencias entre diferentes grupos de riesgo.
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1. Introduction
A virtual microscope system is comprised by a set of computational tools that allows the
exploration and analysis of digitized slides (Virtual slides). The virtual slides contain a large
amount of information that require an efficient interface and adequate storage. Deployment
of virtual microscopy (VM) systems in the last decade has had a wide impact in medical
education and training [2, 17, 25, 28, 30, 32, 36]. Unlike the pervasive support of tech-
nologies in these specific medical applications, integration of computerized tools into the
routine diagnostic pathological workflow has been limited, likely because these systems re-
quire specialized facilities related with acquisition, digitization, storage and visualization of
the histological samples. Moreover, strategies and tools providing diagnostic assistance do
not offer criteria that aids the interpretative task in the analysis of histophatological images.
Figure 1-1.: Virtual microscopy system graphics interface. Navigation tools allow panning
and zooming operations onto the virtual slides mimicking the operations availa-
ble in a light microscope. Additional features, such as sharing and annotation
tools, are highly regarded. However, the integration of computerized aiding
tools to help the pathologist analysis is still lacking.
Inter and intra subject variability is a crucial problem in several diagnostic tasks. This
variability inevitably introduces noise and biases evaluation of difficult pathological entities.
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The development of automatic analysis and computerized aided diagnostic tools aims to
reduce the impact of such variability by offering quantitative measurements and estimations.
Research Problem
From a visual examination standpoint, many pathological entities are hardly distinguishable.
This difficulty is even worst when establishing the malignancy grade of cancer diseases, case
in which architectural and cellular distortions are present. Identification of visual features
characterizing such changes (pathological markers) are used as evidence of the medical diag-
nosis, yet the visual signs can be very subtle and definitely dependent on the pathologist’s
experience.
Research Question
The research question herein addressed was: How to identify, in an efficient and reproducible
way, visual patterns that allow the discrimination of diseases with different risk/aggressiveness?
Virtual microscopy and variability in histopathology analysis
Histopathology is the study of pathological signs using the microscopic examination of a
biopsy or histological specimen that has been previously processed and spread onto a glass
slide [4]. Visualization of cellular structures by microscopical inspection is achieved with
histological dyes that can bind to several microscopical structures in the tissue. The He-
matoxylin and Eosin (the H&E stain) are the dyes most frequently used for pathological
examination. The hematoxylin has more affinity for chemical components present in the
cellular nucleus, staining the nuclei with a dark blue color, while the eosin is commonly
bounded to chemicals present in the cytoplasm and connective tissue. These elements are
commonly observed in a pink/red color. Work6Hours In spite of the avalanche of medical
imaging modalities (such as magnetic resonance imaging (MRI) or computerized tomography
(CT), among others) providing non-invasive examination of the pathological lesions, histo-
logical examination remains the gold standard for diagnosis of a considerable number of
diseases, including the entire set of cancer diseases [4].
An histopathological examination is performed by an expert pathologist. This analysis con-
sists in a subjective evaluation driven by years of medical training [12, 18, 42]. In general,
a pathologist inspects the tissue structure, the cell distribution, and the cell shape and size
of the pathological sample [54]. Afterwards, the expert reaches a decision about the tissue
anomalies associated to benign or malignant changes. This process is laborious and, as said
before, hampered by inter/intra subject variability. The computerized tools aim to reduce the
impact of this variability by providing the quantitative analysis of several tissular features
[33].
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Automatic analysis of histopathological images
Design and implementation of systems that support pathological diagnosis, require the use
of digital image processing techniques such as: image segmentation, feature extraction algo-
rithms or classification algorithms among others [9]
The visual feature extraction at cellular level allows a nuclei/cell quantification of morpho-
logical characteristics. These quantitative measurements can determine anomalies and their
malignancy grade by quantifying local features, but with no special consideration about the
spatial distribution of the cells. For each nucleus/cell, visual features associated to color,
orientation, intensity and shape (nuclei area, perimeter, eccentricity, among others) can be
extracted [22, 11, 51, 24, 3]. Likewise, at tissular level, features correlating with spatial cell
distribution such as texture information or fractal descriptors capture and describe some
pathological entities [40, 23].
Some applications of the previously mentioned algorithms, integrated to systems supporting
diagnostic decisions have also been proposed. Some pathologies include the neuroblastoma
detection [34, 63], the assisted analysis of renal cancer [68], prostate cancer detection [24]
and breast cancer [51].
Contributions and academic products
This thesis presents some contributions to the virtual microscopy and digital pathology fields.
A main contribution corresponds to the study of the prognostic use of automated pathological
markers in cancer disease. Machine learning algorithms (Deep neural networks and bag of
features representations) were used to assess key histological criteria in digitized histological
samples. Afterwards, quantification of these histological features was compared with either
manual visual inspection grading or alternative gene test scores (which are directly correlated
with cancer recurrence risk). Additional contributions are a novel method that normalizes
the color stains in microscopical studies, microscopical image stitching, and the construction
of graph local features that describe complex histopathological patterns.
The academic products of this work include three (3) accepted journal papers and six (6)
conference papers:
Pre-processing in virtual microscopy
Visualising and analysing histological images require several pre-processing operations. This
issues was studied by a set of publications in which we developed a colour separation of
the hematoxylin and eosin channels from the H& E stain [13]. Since the image depends on
the concentration of these chemicals, the fundamental application of this technique is the
nuclear detection/segmentation and color normalization of digital slides. Also, we proposed
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a robust stitching method for construction of whole slide images acquired by a motorized
microscope[56].
David E. Romo, Jonathan Tarquino, Juan D. Garćıa-Arteaga and Eduardo Romero.
Virtual slide mosaicing using feature descriptors and a registration consistency mea-
sure, Proceedings of the IX International Seminar on Medical Information Processing
and Analysis, 2013.
Raul Celis, David Romo and Eduardo Romero. Blind colour separation of H&E stai-
ned histological images by linearly transforming the colour space, Journal of Microscopy,
vol. 260, no 3, p. 377-388, 2015.
Automated histological concept identification
In these set of publications, the ability of multi-scale descriptors and graph based features
to capture the differences in histopathological concepts from skin whole slide images was
investigated. Specifically, strategies to distinguish between normal histological structures
and basal cell carcinoma were explored [55, 57, 58].
David E. Romo, Juan D. Garćıa-Arteaga, Pablo Arbeláez and Eduardo Romero. A
Discriminant Multi-Scale Histopathology Descriptor using Dictionary Learning, Pro-
ceedings of the SPIE Medical Imaging, 2014.
David Romo-Bucheli, Ricardo Moncayo, Angel Cruz-Roa and Eduardo Romero.
Identifying histological concepts on basal cell carcinoma images using nuclei based sam-
pling and multi-scale descriptors, Proceedings of the 2015 IEEE 12th International
Symposium on Biomedical Imaging (ISBI), New York, 2015, pp. 1008-1011.
David Romo-Bucheli, Germán Corredor, Juan D. Garćıa-Arteaga, Viviana Arias,
and Eduardo Romero. Nuclei graph local features for basal cell carcinoma classification
in whole slide images., Proceedings of the 12th International Symposium on Medical
Information Processing and Analysis (SIPAIM), pp. 101600Q-101600Q, 2016.
Cancer grading - comparison with manual grading
In this publication a multi-scale descriptor is used to characterize the nuclear pleomorphism
grading of breast cancer images [50]. The construction of a nuclei dictionary using the multi-
scale descriptor enables a bag of feature strategy to correctly highlight differences between
microscopical fields labelled with different nuclear grades. The proposed method achieved a
second place in the atypia classification task at the mitos-atypia 2014 challenge 1.
1https://mitos-atypia-14.grand-challenge.org/results2
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Ricardo Moncayo, David Romo-Bucheli, and Eduardo Romero. A Grading Strategy
for Nuclear Pleomorphism in Histopathological Breast Cancer Images Using a Bag of
Features (BOF), Progress in Pattern Recognition, Image Analysis, Computer Vision,
and Applications, LNCS, 2015.
Automated pathological markers and outcome - comparison with
genomic tests
In these set of publications, the correlation between automated pathological markers (such
as mitotic activity and normal gland formation within cancerous regions) and cancer risk
as asserted by genomic test were investigated[61, 59, 60]. In a large set of high power fields
extracted from a population of estrogen receptor positive breast cancer, the pathological
markers were quantified and the correlation with the cancer risk was evaluated.
David Romo-Bucheli, Andrew Janowczyk, Eduardo Romero, Hannah Gilmore, Anant
Madabhushi. Automated tubule nuclei quantification and correlation with oncotype DX
risk categories in ER+ breast cancer whole slide images , Proceedings of the SPIE
Medical Imaging, 2016.
David Romo-Bucheli, Andrew Janowczyk, Eduardo Romero, Hannah Gilmore, Anant
Madabhushi. Automated tubule nuclei quantification and correlation with oncotype DX
risk categories in ER+ breast cancer whole slide images, Nature Publishing Group,
Scientific Reports, vol. 6, no. 32706, 2016.
David Romo-Bucheli, Andrew Janowczyk, Eduardo Romero, Hannah Gilmore, Anant
Madabhushi. A deep learning based strategy for ideintifying and associating mitotic ac-
tivity with gene expression derived risk categories in estrogen receptor positive breast
cancers, Cytometry Part A, 2017. doi:10.1002/cyto.a23065
Thesis outline
The remaining chapters of the thesis are organized as follows:
Chapter 2: Automated tubule nuclei quantification and correlation with
oncotype DX risk categories in ER+ breast cancer whole slide images
This chapter presents a comparison between the automated tubule quantification and
the cancer risk in breast cancer. A deep learning model was used to identify nuclei
belonging to a tubular structure. After this, the model is used to quantify the tubule
formation in groups of low, intermediate and high risk breast cancer. The resulting
measurements are correlated with the different cancer risk groups.
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Chapter 3: A deep learning based strategy for identifying and associa-
ting mitotic activity with gene expression derived risk categories in Es-
trogen Receptor Positive Breast Cancers In this chapter a deep learning model
to identify mitosis is presented. The model is used to quantify the mitotic activity in
a population of breast cancer specimens that have a high, intermediate and low risk
of recurrence, as asserted by the Oncotype DX genome test. The quantified mitotic
activity is compared with the risk groups.
Chapter 4: Conclusions The final chapter in this work presents some conclusions
and discuss the potential impact of automated pathological markers in histological
image analysis. Also, future research directions and perspectives are discussed.
2. Automated Tubule Nuclei
Quantification and Correlation with
Oncotype DX risk categories in ER+
Breast Cancer Whole Slide Images
Early stage estrogen receptor positive (ER+) breast cancer (BCa) treatment is based on
the presumed aggressiveness and likelihood of cancer recurrence. Oncotype DX (ODX) and
other gene expression tests have allowed for distinguishing the more aggressive ER+ BCa
requiring adjuvant chemotherapy from the less aggressive cancers benefiting from hormonal
therapy alone. However these tests are expensive, tissue destructive and require specialized
facilities. Interestingly BCa grade has been shown to be correlated with the ODX risk score.
Unfortunately Bloom-Richardson (BR) grade determined by pathologists can be variable. A
constituent category in BR grading is tubule formation. This study aims to develop a deep
learning classifier to automatically identify tubule nuclei from whole slide images (WSI) of
ER+ BCa, the hypothesis being that the ratio of tubule nuclei to overall number of nuclei
(a tubule formation indicator - TFI) correlates with the corresponding ODX risk categories.
This correlation was assessed in 7513 fields extracted from 174 WSI. The results suggests
that low ODX/BR cases have a larger TFI than high ODX/BR cases (p < 0,01). The low
ODX/BR cases also presented a larger TFI than that obtained for the rest of cases (p < 0,05).
Finally, the high ODX/BR cases have a significantly smaller TFI than that obtained for the
rest of cases (p < 0,01). The complete content of this chapter was published in Scientific
Reports Journal [59].
2.1. Introduction
The primary conundrum in treatment and management of early stage estrogen receptor
positive (ER+) breast cancer (BCa) is identifying which of these cancers are candidates
for adjuvant chemotherapy and which patients will respond to hormonal therapy alone.
ODX and other gene expression tests have allowed for distinguishing the more aggressive
ER+ BCa requiring adjuvant chemotherapy from the less aggressive cancer benefiting from
hormonal therapy alone. However these gene expression tests tend to be expensive, tissue
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destructive and require physical shipping of tissue blocks for the test to be done. Interestingly
BCa grade in these tumors has been shown to be highly correlated with the ODX risk score
[38, 65, 1]. Unfortunately studies have shown that Bloom Richarsdon (BR) grade determined
by pathologists can be highly variable [21]. The three constituent categories within the
BR grading system are mitotic index, tubule formation and nuclear pleomorphism. Tubule
formation is defined as the percentage of cancer tissue that still contains normal tubules.
According to Elston and Ellis guidelines [26], tumor cell clusters with glandular formation are
also counted (Figure 2-1 shows some examples of tubule delineations for low and high risk
BCa). Tubule scoring is determined by estimating tubule area and assigning to one of three
categories: (i) > 75 %, (ii) between 10 %−75 %, and (iii) < 10 %. However, this estimation is
highly influenced by experience of the pathologist. Additionally, previous studies have shown
the correlation between manually determined tubule score and ER+ breast cancer prognosis
and ODX risk categories[29, 39].
Figure 2-1.: Breast Cancer tissue showing (left) high and (right) low tubule formation.
Lumen is delineated by blue lines. Tubules are delineated by orange lines,
where nuclei inside these boundaries represent the tubule nuclei used in our
approach. Green and red dots correspond to nuclei candidates classified as
tubule or non-tubule nuclei by our DNN classifier. In the high ODX (right)
image, the cells have lost their capacity to form tubules with a rounded lumen.
.
Since histologic criteria (such as tubule, nuclei pleomorphism, and mitotic activity) are used
in pathological grading systems, several works using automated extraction algorithms have
been proposed to quantify such criteria [67]. Tubule detection has been previously addressed
in the literature [20, 7, 48]. Typically these approaches focus on the identification of tubule
lumen (see Figure 2-1). Strategies focused on identifying tubules based off the lumen present
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a couple of challenges. Firstly the shape and size variability of the gland lumen makes
accurate modeling of the tubules difficult. Secondly several structures, besides tubules, also
contain lumen, i.e., blood vessels and other types of glands. Morphological operators have
been used to connect proximal cancerous cells and generate blob structures [20]. These
blobs were identified as tubules when they were found to be surrounding a white space or
lumen. Another approach using the O’Callaghan neighborhood graph to impose structural
constraints on lumen, allowed for identification of true lumen with an accuracy of 86 % [7].
An accuracy of 89 % was obtained in the classification task of low (tubular BR score 2 and 3)
and high tubule formation (tubular BR score 1). A similar strategy, using k-means to identify
lumen followed by a level set based segmentation approach enabled the identification of the
surrounding nuclei layer [48].
The deep neural network (DNN) is a deep learning architecture that comprises more than
two hidden layers. In supervised classification settings, a DNN uses the backpropagation
algorithm to update its internal weights according to the label of input exemplars [41]. Some
applications of the DNNs in histological image analysis include the mitosis identification task
[16] and the localization of regions of interest in histological images [19].
With the recent emergence of whole slide tissue scanning and digital pathology [47, 10, 31]
there has been substantial interest in developing automated computerized histologic pre-
dictors of tumor grade and outcome for several diseases including oropharyngeal squamous
cell carcinoma [46], prostate cancer [45, 44] and glioblastoma [14]. The correlation of com-
puterized extracted features with breast cancer survival has also been explored. Beck et al.
[8] performed a comprehensive analysis of several automatically quantified morphological
features and their relationship with breast cancer survival. The authors reported a strong
association of automatically extracted stromal features with survival in a set of 576 H&E
breast cancer tissue microarray (TMA) images. Tambasco et al. [64] used fractal analysis
to compute the morphological complexity of 379 pan-cytokeratin stained TMA images. A
significant association of survival with the computed fractal dimension was found. The corre-
lation of automated extracted features with Oncotype DX risk score and risk categories has
been investigated in a couple of studies. Basavanhally et al. [6] showed that nuclear graphs
built using Delaunay triangulation and minimum spanning trees can be used to distinguish
breast cancer images with low and high recurrence ODX scores (RS). The authors used 37 H
& E stained images from a cohort of 17 patients at 20× magnification and obtained a mean
accuracy of 84,15 % in distinguishing samples with low and high RS. Also, the combination
of computer extracted features from both H&E and CD34 IHC stained images in a cohort of
29 patients (9 with low RS, 11 intermediate RS and 9 with high RS) [5] was shown to distin-
guish high and low ODX risk patients. The authors reported an average classifier accuracy of
91 % for distinguishing high and low RS cases. Other studies have explored the association
between manually identified pathological measurements (e.g. nuclei grade, mitotic index,
tubule degree) and the Oncotype DX score. Both Flanagan et al. [29] and Klein et al. [39]
used regression analysis to obtain a set of equations that predicts Oncotype DX score based
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on histological variables such as nuclei grade, mitotic index, tubule formation degree among
others. After eliminating cases from the intermediate risk category, concordance between
the ODX score and the estimated score (using the obtained equations) range from 96,9 % to
100 %.
The contributions of the work presented in this paper are twofold. Firstly we aim to evalua-
te a customized DNN for automatic quantification of tubules in whole slide images (WSI).
Secondly we seek to evaluate whether tubule score automatically identified by the DNN is
correlated with the risk categories determined by ODX in a cohort of 174 patients. Our
approach comprises the following main steps. First, a blue ratio transform is used to detect
nuclei candidates. Image patches, each containing a nucleus, are then extracted. These pat-
ches are manually labeled as containing a tubule or not. The patches are used to train a
DNN classifier to identify tubule nuclei in WSI. After tubule nuclei identification, the ra-
tio between tubule nuclei and overall number of nuclei is computed as a tubule formation
indicator (TFI).
The rest of this paper is organized as follows: Section 2 describes the methodology used for
training and testing the DNN tubule nuclei classifier. Section 3 presents the experimental
design to study the correlation of the TFI with ODX risk categories. Section 4 describes the
results of the statistical experiments and the distribution of the TFI for the ER+ BCa cases.
Finally, in Section 5 we present the main conclusions of our work.
2.2. Methodology
The whole methodology to use the automated TFI to study its correlation with ODX score
and BR grading in WSI is presented in Figure 3-1.
2.2.1. Nuclei detection
First, an automated algorithm based on blue ratio transformation[15] is used to detect nuclei.
After computing the blue ratio transform, a global threshold computed by using Otsu’s
method [52] is used to obtain a binary image. Then, an opening operation is applied. The
centroid of each connected component corresponds to the centroid of a nucleus candidate. The
nuclei detection algorithm is a lightweight method that provides a nuclei rough estimation
that was found to be representative of the true nuclei population in terms of the TFI, as
shown by the experiments described in the supplementary information (See Appendix G).
2.2.2. Curating the Learning Set
An RGB patch is extracted (size 64 × 64 at 20× magnification with a spatial resolution of
approximately 0,5µm per pixel) around the centroid of each candidate nuclei. This patch
12
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Figure 2-2.: Overall diagram flow showing the steps to analyze the correlation of the tubule
formation indicator with ODX score and BR grade. Several high power fields
from a whole slide images are extracted. A nuclei detection method is then
applied on each high power field. Each of the candidate nuclei is classified as
tubule or not using a DNN classifier. Subsequently, the mean tubule nuclei
ratio to total number of nuclei per high power field for each whole slide image
is computed and analyzed with respect to the corresponding ODX risk category
and BR grade.
is labeled as either tubule or not, according to an annotation supplied by an expert pat-
hologist (The expert breast pathologist annotation corresponds to a manual delineation of
each tubule). These pathologist annotated patches are then used to train the DNN classifier.
Exemplar RGB patches belonging to the tubule class and non-tubule class are presented in
Figure 2-3.
Figure 2-3.: Examples of image patches used for training. Top Row: The tubule class.
Bottom row: The non-tubule class. Each patch center corresponds to a nu-
cleus candidate centroid.
The DNN architecture is illustrated in Figure 3-2 and is composed of three blocks: a con-
volution neural network (CNN), a Rectifier Linear Unit (ReLU) and a maximum pool (max
pool) operator. Finally, two fully connected layers yield the probability representing the
membership of the nucleus to the tubule class.
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2.2.3. Independent testing of the DNN classifier
During testing, the nuclei detection algorithm is used to identify candidate nuclear centroids.
These patches then fed to the DNN, as shown in Figure 3-2. This process enables the
generation of their tubule class membership probability. If the probability is higher than 0,5,
the patch is assigned to the tubule class.
Figure 2-4.: Deep learning architecture used to classify nuclei. A patch containing a nucleus
feeds the deep neural network. The probability of the nucleus being part of a
tubule is based on the output of the deep neural network classifier.
The DNN performance was evaluated on a dataset with 61 high power fields that were
extracted from 11 WSI. Whole tubule structures (including epidermis surrounding the lumen)
had been previously annotated by an expert pathologist. A 5-fold cross validation setup was
used, ensuring each fold was split at the patient level.
Evaluation measures (Fscore, precision, recall (sensitivity) and specificity for the tubule nuclei
class[53]) were computed for each of the 5-folds. The average +/- standard deviation of the
Fscore, precision, recall and specificity were: 0,59±0,14, 0,72±0,12, 0,56±0,2 and 0,9±0,06
respectively (see Figure 2-5).
Observe that the recall for the tubule identification is lower than the specificity, indicating
that a classification error is more likely for a tubule nuclei than for a non-tubule nuclei.
Also, the variability of tubule sizes and shapes may explain the higher standard deviation
obtained with the recall measure. Detailed results for each fold are presented in Table 2-1.
The detection results in Table 2-1 suggest that the tubule detector has a high specificity,
a finding that might be caused by the unbalanced nature of the problem (there is a larger
number of non-tubule nuclei as opposed to tubule nuclei in the BCa specimens). Also the
tubule nuclei exhibit a substantially large inter-subject variation. The tubule nuclei samples
used during training might not be adequate to capture all the variability observed in tubules
from different patients.
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Figure 2-5.: Performance evaluation measures for the tubule nuclei detection task in a 5-




A set of WSI extracted from 174 patients with ER+ BCa were used in this study. At most 50
high power fields per WSI were selected: the selected high power fields were those with the
lower number of tubule nuclei ratio. This selection avoids high power fields with unusually
large number of detected tubule nuclei (outliers). All of these high power fields were sampled
from cancerous regions previously identified by an expert pathologist.
2.3.2. Correlation with ODX risk groups via t-test analyses
After identifying the tubule nuclei the TFI was computed: the ratio between the tubule
nuclei and the total number of nuclei. This TFI is evaluated as a potential risk predictor.
In order to compare the TFI with the risk associated to each BCa sample, the set was
divided into a) High, b) Intermediate and c) Low risk categories according to the ODX
score. Additionally, the BR grade is also used to define: d) The high ODX-high grade group
(with both high ODX and BR score-HH), e) The low ODX-low grade group (with both
low ODX and BR score-LL), f) All the BCa cases that don’t belong to the HH group (HHc
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F-score Precision Recall (Sensitivity) Specificity
Fold 1 0,34 0,89 0,21 0,98
Fold 2 0,7 0,73 0,67 0,9
Fold 3 0,71 0,81 0,63 0,93
Fold 4 0,64 0,59 0,7 0,84
Fold 5 0,59 0,59 0,59 0,83
Average 0,59± 0,14 0,72± 0,12 0,56± 0,2 0,9± 0,06
Table 2-1.: 5-Fold validation results for the tubule detection across N = 11 patients. The
F-score, precision, recall and specificity for the tubule classification are shown.
The final row presents the average and standard deviation for each of the four
measures across all N = 11 patients and across the 5 folds.
group) and g) All the BCa cases that don’t belong to the LL group (LLc group). The dataset
categorization is indicated in Table 2-2.
The t-test statistical analysis was applied to compare the distribution of the automated TFI
with the high, intermediate and low ODX risk groups as well as the BCa cases with both a
high ODX score and high grade and also cases with both low ODx score and low BR grade.
The t-test for all the experiments was performed with equal mean and unequal variance
hypothesis. Specifically, the t-test was applied to compare the different groups as described
below:
The high ODX group against the low ODX group
The high ODX group against both the intermediate and low ODX group
The low ODX group against both the high and intermediate ODX group
The high ODX-high grade (HH Group) against the low ODX-low grade (LL group)
The high ODX-high grade (HH Group) against all the other cases (HHc group) and
The low ODX-high grade (LL group) against all the other cases (LLc group)
2.3.3. Correlation with ODX risk groups via ROC analysis
The risk prediction capability of the TFI was also evaluated using a Receiver Operating
Curve (ROC). For doing so, the binary classification task was based solely in the tubule
nuclei ratio: each WSI with a mean tubule ratio above a particular threshold is classified as
low ODX. By varying the threshold from [0, 1] is possible to generate the ROC curve. In this
particular experiment the goal was to distinguish the HH and LL categories (see Table 2-2).
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BCa Groups Description Number of cases
High ODX ODX > 30 24
Low ODX ODX < 18 95
Intermediate ODX 18 ≤ ODX ≤ 30 55
High ODX-high grade (HH) Both ODX > 30 and BR > 7 15
Low ODX-low grade (LL) Both ODX < 18 and BR < 6 42
HHc group All BCa cases that do not belong to HH group 159
LLc group All BCa cases that do not belong to LL group 132
Table 2-2.: ODX score and BR grading rules used to split the dataset into high, intermediate
and low ODX categories. The corresponding number of cases for each group is
presented in the last column.
2.4. Results
2.4.1. Correlation with ODX and BR risk categories via t-test analyses
The DNN classifier was applied to the 174 WSI previously described. Qualitative results for
high, intermediate and low ODX cases can be seen in the Figure 2-6. The significant t-test
results for the comparison between the risk groups is presented in Table 3-1.
Risk group p-values
comparison (Unequal variance)
H vs L 0.1633
H vs L and I 0.2731
H and I vs L 0.0998
HH vs LL 0.0021
LLc vs LL 0.0145
HH vs HHc 0.0097
Table 2-3.: Statistical comparison of the deep learning tubule classifier in distinguishing
different risk groups. Note that statistically significant differences were only
observed for 3 of the 6 comparative experiments performed.
When observing the group distribution according to ODX score, it is difficult to distinguish
between low and high ODX groups. However, when combined ODX and BR groups are
analyzed, the high and low risk groups show different distributions as shown in Figure 2-7.
Results in Figure 2-7 reveal that the automated TFI is significantly different for the groups
that have low ODX-low grade and high ODX-high grade. The HH group had a mean tubule
nuclei ratio per high power field of 0,029. In contrast, the LL group had a mean tubule
nuclei ratio of 0,126. The two groups are significantly different (p < 0,01 with 95 % CI [0,04,
0,16]). The differences in the TFI is still significant when we compare the HH group against
the BCa cases that did not belong to this group (p < 0,01 with 95 % CI[0,013, 0,085]). The
mean for non HH cases was 0,078. Finally, the difference in the average TFI value was also
significant when comparing the LL group with the BCa cases outside this group (p < 0,05
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Figure 2-6.: Tubule nuclei identification process for high power fields extracted from low
ODX (top row), intermediate ODX (middle row) and high ODX (bottom row)
breast cancers. In the first column, the high power field at ×20 magnification is
depicted. In the second column, the resulting mask showing the nuclei centroids
after the nuclei detection process is presented. The third column shows the
DNN classification of each nucleus either as a tubule nucleus (green dot) or a
non-tubule nucleus (blue dots). Each image in the right column corresponds
to a close up in the selected region (orange rectangle) depicted in the left most
column. For the low ODX high power field, a significant number of tubule
nuclei are identified. Observe also that some false negatives are not uncommon
in the nuclei surrounding the tubule lumen. On the other hand, the high and
intermediate cases have a substantially lower number of tubule nuclei. Some
false positive (false tubule nuclei) errors are also visible in the right most
column.
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Figure 2-7.: Violin plots depicting the mean tubule nuclei ratio in high power fields ex-
tracted from the different ODX risk groups. The histogram associated to each
violin plot is smoothed using a normal kernel. Red lines in the violin plot show
the location of the lower quartile (q1), the median and the upper quartile (q3).
Low (blue), intermediate (yellow) and high (green) ODX groups are shown in
the top row (a). The distribution of the low and intermediate groups (cyan)
against the high ODX group is presented in (b). The low group against the
intermediate and high ODX groups (magenta) are presented in (c). The dis-
tribution for the groups with low ODX-low grade and high ODX-high grade
are depicted in (d). High ODX-high grade against all the other BCa cases and
low ODX-low grade against all the other BCa cases are presented in (e) and
(f) respectively.
2.4 Results 19
with 95 % CI[0,014, 0,12]). The cases that did not belong to the LL group had a mean tubule
nuclei ratio of 0,057.
2.4.2. Correlation with ODX and BR risk categories via ROC curve
The distribution of the histologic images (ODX score vs tubule nuclei ratio) for the HH and
LL groups is shown in the left column of Figure 2-8. While a low mean tubule nuclei ratio
appears to require additional analysis to determine its risk category, it is observed that a
WSI with a high tubule nuclei ratio is very likely to be member of the low ODX risk category.
Figure 2-8.: (a) Receiver operating characteristic (ROC) curve for the prediction of low
ODX using only the tubule nuclei ratio feature. (b) Mean automated tubule
nuclei ratio for each whole slide image. The high (red) and low (blue) ODX
score groups are depicted. The x-axis represents the underlying ODX score of
each sample. The y-axis represents the tubule nuclei ratio. Observe that the
high ODX image have a low tubular density. A high tubule nuclei ratio is very
likely associated with a low ODX image. Optimal threshold obtained for the
ROC curve (threshold at which the ROC curve is closest to point [0, 1]) is also
shown.
The Receiver Operating Curve (ROC) for the binary classification task using only mean
tubule nuclei ratio for each WSI is presented in the right column of Figure 2-8. The WSI
with a mean tubule ratio above the threshold is classified as low ODX. The ROC curve shows
that the tubule nuclei ratio yields an area under the curve (AUC) of 0,76 in distinguishing
the low ODX-low grade from the high ODx-high grade categories.
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2.5. Concluding Remarks
In this paper we rigorously investigated the problem of objectively computing the tubule
nuclei ratio, a potential computational histologic image biomarker of disease risk and ag-
gressiveness in ER+ BCa. To evaluate whether automatically TFI was associated with the
risk category determined by the Oncotype DX test, a deep learning classifier was developed
to automatically identify tubules based off the surrounding nuclei. The automatically deter-
mined TFI was then evaluated in terms of its ability to distinguish the low and high ODX
risk categories and cases with different permutations of ODX risk and grade. On a cohort of
174 WSI, the TFI was found to be significantly different for the BCa cases with low ODX-low
grade and high ODX-high grade. When comparing the high ODX-high grade group with all
the other BCa cases, the TFI was still significantly lower. Likewise, the calculated tubule
quantification measure was larger in the BCa cases with low ODX-low grade compared to
the remaining BCa cases.
The automated TFI appears to have a slightly weaker correlation with ODX risk categories
than other previously investigated computerized image features such as nuclear architecture
[6]. However it has been previously shown that using a combination of automated features
(even extracted from differently stained samples from the same patient), might increase the
ability to predict the corresponding ODX risk category [5]. Hence, developing strategies to
integrate information from predictors that use different histological features (e.g. nuclear
architecture, mitotic count, tubule density) will be a future research endeavor.
Automated tubule quantification could be potentially useful in streamlining clinical patho-
logy workflows. The automated quantification aims to standardize the breast cancer grading
and risk assessment process and reduce inter-reader variability. Our newly presented method
was evaluated within manually selected cancerous regions. However, automatic delineation
of regions of diagnostic interest is an open research problem [19]. Future work will focus on
improving the tubule detector performance, validating our approach on larger test cohorts
and incorporating automatic region of interest selection methods.
3. A deep learning based strategy for
identifying and associating mitotic
activity with gene expression derived
risk categories in Estrogen Receptor
Positive Breast Cancers
The treatment and management of early stage estrogen receptor positive (ER+) breast can-
cer is hindered by the difficulty in identifying patients who require adjuvant chemotherapy
in contrast to those that will respond to hormonal therapy. To distinguish between the more
and less aggressive breast tumors, which is a fundamental criterion for the selection of an ap-
propriate treatment plan, Oncotype DX (ODX) and other gene expression tests are typically
employed. While informative, these gene expression tests are expensive, tissue destructive,
and require specialized facilities. Bloom-Richardson (BR) grade, the common scheme em-
ployed in breast cancer grading, has been shown to be correlated with the Oncotype DX
risk score. Unfortunately, studies have also shown that the BR grade determined experiences
notable inter-observer variability. One of the constituent categories in BR grading is the mi-
totic index. The goal of this study was to develop a deep learning (DL) classifier to identify
mitotic figures from whole slides images of ER+ breast cancer, the hypothesis being that
the number of mitoses identified by the DL classifier would correlate with the corresponding
Oncotype DX risk categories. The mitosis detector yielded an average F-score of 0,556 in
the AMIDA mitosis dataset using a 6-fold validation setup. For a cohort of 174 whole slide
images with early stage ER+ breast cancer for which the corresponding Oncotype DX sco-
re was available, the distributions of the number of mitoses identified by the DL classifier
was found to be significantly different between the high vs low Oncotype DX risk groups
(p < 0,01). Comparisons of other risk groups, using both ODX score and histological grade,
were also found to present significantly different automated mitoses distributions. Additio-
nally, a support vector machine classifier trained to separate low/high Oncotype DX risk
categories using the mitotic count determined by the DL classifier yielded a 83,19 % classi-
fication accuracy. The complete content of this chapter was published in Cytometry Part A
journal [60].
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3.1. Background
Modern treatment of early stage estrogen receptor positive (ER+) breast cancer requires
a precise identification of which cases will benefit from additional adjuvant chemotherapy
versus those indicating solely hormonal therapy. A distinction between the more and less
aggressive breast tumors, required for planning the treatment, is usually performed with
Oncotype DX (ODX) and other gene expression tests. In general, the more aggressive cancers
require adjuvant chemotherapy while the more benign respond well to hormonal therapy
alone. However these gene expression tests tend to be expensive, tissue destructive, and
require specialized facilities for processing.
The Oncotype DX risk score has been demonstrated to be highly correlated with breast can-
cer grade [38, 65, 1]. Unfortunately, the grades yielded by the standard Bloom-Richardson
system (BR) have been found to be highly variable as a result of both observer experience
and tumor presentation[21]. The BR consists of assigning a value to stratify three proper-
ties: (a) the nuclear pleomorphism score aims to characterize the variance in nuclear size
and appearance, (b) the tubule density score is intended to reflect the percentage of cancer
tissue that contains normal tubules, and (c) the mitotic index aims to quantify the number
of mitoses in a specific number of high power fields (HPFs; typically 10)[27]. Although the
number of mitoses is regarded as an important prognostic indicator, the overall predictive
power is limited by significant inter-reader variability due to potentially differently selec-
ted fields[49]. In spite of these challenges, studies have shown that Oncotype DX is highly
correlated with the mitotic grade for ER+ breast cancers[29].
The recent addition of whole slide imaging capabilities to pathology has sparked notable
interest in the use of automated computerized histologic predictors of tumor grade and
outcome [46, 45, 44, 14]. In the context of breast cancer, Basavanhally et al. [6] showed that
nuclear graphs built using Delaunay Triangulation and Minimum Spanning Trees can be
used for distinguishing low and high recurrence score breast cancer cases.
Of late, there has been substantial interest in automating the process of identifying mitotic
figures in whole slide pathology images [67]. Larsen et al. [43] used color intensity histograms,
gradient orientation histogram and shape index histograms to identify mitoses. Wang et al.
[69] proposed to use a convolution neural network and a set of handcrafted features combined
with a random forest classifier to identify mitotic figures in WSI. Janowczyk et al. [37] used
deep learning approaches to perform several histologic image analysis tasks, including mitotic
identification. Veta et al. [66] evaluated the performance of several state-of-the-art mitotic
detection methods and found that a Deep Neural Network (DNN) yielded the best overall
performance with an overall F-score of 0,61 [16] in the test set of the AMIDA2013 challenge
[66].
A neural network architecture consisting of more than two layers is commonly referred as a
deep neural network. In supervised classification settings, a DNN uses the backpropagation
algorithm to update its internal weights according to the label of input exemplars [41]. The
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DNN for mitotic detection is usually trained using a set of image patches that are within a
defined d pixel radius to a mitotic nuclei [16].
The contributions of the work presented in this chapter are twofold. Firstly we aim to
evaluate a customized DNN for automatic quantification of mitosis in WSI. Secondly, we
seek to evaluate whether the automated mitotic index identified by the DNN correlates with
the risk categories determined by ODX.
3.2. Experimental Methods
The methodology used to automate mitotic nuclei identification and classify WSI into risk
BCa groups as defined by both ODX score and BR grading is illustrated in Figure 3-1.
Figure 3-1.: Overall diagram flow showing the steps to analyze the correlation of the au-
tomated mitotic count with ODX and to use mitotic information in BCa risk
stratification. In the training stage, high power fields (HPFs) from several WSI
are extracted and a nuclei detection method is applied on each high power field.
Each of the candidate nuclei is classified as mitotic or not using a DNN clas-
sifier. Subsequently, the mitotic information is used to train a linear support
vector machine classifier. At testing stage, nuclei identification algorithm and
the DNN classifier are used again in the cancerous regions of the WSI. Fi-
nally, the resulting mitotic information is used by the support vector machine
classifier to predict the WSI risk either as high or low.
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3.2.1. DNN for mitotic identification
The mitosis detection module involved the training of a DNN model with Hematoxylin
and Eosin stained images. Candidate nuclei were found by an automated nuclei detection
algorithm at 40X magnification. Candidate nuclei, separated by less than 20 pixels from
the expert annotations, were labeled as mitotic. The approach starts by mapping each RGB





The resulting image highlights the chromatin information (observable in mitotic nuclei) and
an adaptive threshold converts the blue ratio image into a binary map, using the gray-level
histogram information. The optimal threshold is supposed to maximize the separability of
two resulting pixel clusters [52]. Subsequently, a set of morphological operations (closing
and opening) further improve the selection of the candidate nuclei by removing noise. The
connected components are finally selected as candidate nuclei. The centroid of each candidate
nucleus corresponds to the center of the associated RGB color patch (size 64 × 64 at 40×
magnification) which is then fed into the DL classifier to determine whether or not it is a
mitotic nucleus.
Figure 3-2.: Deep learning architecture for mitosis detection. A 64 × 64 size patch is ex-
tracted at 40× magnification. The patch contains a candidate nucleus which
is fed to the DNN. The DNN is composed of several convolutional neural net-
works, each followed by non-linear and pooling operations. At the end, two
fully connected layers are used to estimate the probability of a patch contai-
ning a mitotic figure. The probability that the image patch contains a mitotic
nucleus is then assigned by the classifier.
The DNN architecture in Figure 3-2 consists of three identical blocks, each composed of
a convolution neural network (CNN), a Batch normalization layer, a Rectifier Linear Unit
(ReLU) and a maximum pool (max pool) operator. Each CNN layer corresponds to a set of
convolutional filters learned from the mitotic and non-mitotic classes. The Batch normaliza-
tion layer imposes a transformation of the neural weights to solve the internal covariate shift
problem[35]. In practice, this normalization layer allows the method to achieve improved
learning rates during the DNN training stage. The proposed network architecture reduces
the input patch to an output signal which coincides with the probability that the input
contains a mitotic event. Stochastic gradient descent is used to minimize the negative log
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likelihood loss criterion, which is a measure that quantifies the classification error in the
neural network.
The light design of the DNN, along with the nuclei sampling strategy, reduces the compu-
tational burden at test time as the cancerous regions in whole slide images can cover over
500 HPFs at 40× magnification. As such, an appropriate strategy combined with a suitable
DNN architecture is necessary to meet the time constraints and requirements of a typical
clinical workflow.
The DNN classifier was trained using image patches extracted from two open access datasets:
225 (from MITOS2012 [62]) and 516 mitotic events (from AMIDA2013 [66]). Non-mitotic
candidate nuclei were extracted using an automatic nuclei detector. The performance of the
DNN was evaluated with the AMIDA2013 training dataset under a 6-fold cross-validation
setup and each fold was split at the patient level. The Fscore, Precision and Recall measures
[53] for the mitotic nuclei class were computed across the 6-folds. The average and the
standard deviation for the Fscore, precision and recall measures of the 6 folds were: 0,556±
0,21, 0,47 ± 0,24 and 0,78 ± 0,11, respectively. The mitotic classifier was also evaluated on
the MITOS2012 testing set (using the AMIDA2013 and MITOS2012 training sets to train
the DNN) obtaining a 0,78 Fscore.
3.2.2. Support Vector Machine for BCa risk stratification
The DNN mitotic detector can be used on several HPFs from a WSI to assess the mitotic
frequency in the respective cancerous regions. The obtained mitotic frequency information
is then used to build a feature vector of 10 dimensions, each bin (dimension) representing
the number of high power fields with [k ∈ 0, 1..,8, and k ≥ 9] mitotic figures. Since the
cancerous regions in each BCa case have a different number of HPFs, the feature vectors are
normalized. Each feature vector is centered and scaled by a unitary standard deviation. The
collected feature vectors were used to train a support vector machine with a linear kernel in
order to distinguish BCa cases labeled either as low or high risk.
3.3. Experimental Design
3.3.1. Whole Slide Data Description
The 174 Whole Slide Images (WSI) are diagnosed with the Bloom Richardson (BR) grading
system and ODX. The dataset was split into (a) High (24 WSI, ODX > 30), (b) Intermediate
(55 cases and 18 ≤ ODX ≤ 30) and (c) Low Risk categories (95 WSI and ODX < 18).
Additionally, BR score defined another two risk subgroups: (d) 15 cases with both high
ODX and high BR grade (BR > 7) and (e) 42 cases with both low ODX and low BR grade
(BR < 6).
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From the 174 WSI, a total of 20082 high power fields were extracted. Each high power field
corresponds to an image of 2000×2000 pixels at 40× magnification (a pixel is ≈ 0,0625µm2).
The performance of the DNN mitosis detector described in Subsection ‘DNN for mitotic
identification’ was also evaluated in a subset of the images from these 174 WSI. A total
of 40 HPFs were randomly selected from BCa cases that have either high ODX-high grade
or low ODX-low grade. Mitoses in these images were annotated by an expert pathologist
collaborator. Evaluation of the DNN performance yielded an overall 0,56 F-score measure
in the aforementioned set of images. This measure is within the range previously reported
(0,556± 0,21) in Subsection ‘DNN for mitotic identification’. A detailed presentation of the
results is included in the Supplementary File B (See Appendix I).
3.3.2. Experiments and statistical analysis
The correlation of the automated mitosis with the ODX and BR groups was assessed in two
different ways. First, a t-test evaluated the differences of the obtained mitotic counting for
the different risk groups defined in Subsection ‘Whole Slide Data Description’. Second, to
evaluate the hypothesis that the automatically estimated mitotic count enables discrimina-
tion of the high/low ODX groups, a Support Vector Machine classifier was trained and used
to classify WSI into high and low risk BCa.
A mean “mitotic count per ten high power fields̈ıs computed for each WSI. The distribution
is then compared for the two risk groups using a two tail t-test. The null hypothesis is that
both distributions are sampled from the same normal distribution with equal mean. The
t-test is applied using an equal variance for the different risk groups, specifically: (a) The
high ODX group against the low ODX group, (b) The high ODX group against both the
intermediate and low ODX group, (c) The high ODX-high grade (HH Group) against the
low ODX-low grade score (LL group), (d) The high ODX-high grade (HH Group) against
the rest of cases (HHc group) and (e) The low ODX-low grade (LL group) against the rest of
cases (LLc group). The main hypothesis to test in each of the aforementioned experiments
is that the BCa groups with higher ODX score and BR grading have a higher number of
mitotic figures.
The discriminability of the number of mitotic figures automatically identified by the deep
learning classifier was assessed in a BCa risk stratification task. The support vector machine
classifier, described in Subsection ‘Support Vector Machine for BCa risk stratification’, was
evaluated using a leave-one-out cross-validation scheme for each of the BCa cases (WSI)
labeled either as high risk (BCa cases with high ODX score 24 cases) or low risk (BCa
cases with low ODX score and low grade - 95 cases). The SVM classifier was trained with a
regularization hyperparameter C = 1.
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Figure 3-3.: Mitosis identification process in HPFs extracted from low ODX BCa (top row),
intermediate ODX BCa (middle row) and high ODX BCa (bottom row). In
the first column, results of the mitosis detection for the original HPF at 40X
magnification is depicted. In the second column, the mask after the nuclei
detection process is presented. The third column shows a close up for the
DNN detection of the mitoses (green circles) depicted in the left most column.
Mitosis are rare events: at the selected HPF size the low ODX Bca cases usually
does not have mitosis. Meanwhile, intermediate and high ODX HPFs have a
slightly larger mitosis count.
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3.4. Experimental Results and Discussion
3.4.1. Statistical Analysis
The DNN classifier was applied to the 174 WSI previously described in Subsection ‘Whole
Slide Data Description’. Qualitative results for high, intermediate and low ODX cases can
be seen in Figure 3-3. Distributions of the average mitotic count for the high, intermediate
and low ODX groups are depicted as violin plots in Figure 3-4 (see caption for violin plot
description). Additionally, the intermediate group is paired either with the high or the low
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Figure 3-4.: Violin plots depicting the mean mitotic activity in 10 HPFs for the different risk
ODX risk groups. The histogram associated with each violin plot is smoothed
using a normal kernel. Red lines in the violin plot show the location of the
lower quartile (q1), the median and the upper quartile (q3). Low (orange),
intermediate (yellow) and high (green) ODX groups are shown in the top row
(a). The mitotic distribution of the low and intermediate groups (cyan) against
the high ODX group is presented in (b). The mitotic distribution of the low
group against the intermediate and high ODX groups (purple) are presented
in (c). The mitotic distribution for the groups with low ODX-low grade and
high ODX-high grade are depicted in (d). The mitotic distribution for the high
ODX-high grade against the rest of BCa cases, and low ODX-low grade against
the rest of BCa cases are presented in (e) and (f) respectively.
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The mean mitotic distribution in 10 HPF was computed for high ODX and BR scores (HH)
and for low ODX and BR scores (LL), as illustrated in the bottom row of Figure 3-4. The
distributions of both groups was compared against the rest of BCa cases. The t-test results
are presented in Table 3-1.
Risk group p-values
comparison (Equal variance)
H vs L 0,1× 10−3
H vs L and I 3,6× 10−3
H and I vs L 2,3× 10−3
HH vs LL 0,2× 10−3
LL vs rest of Bca cases (LLc) 0,032
HH vs rest of Bca cases (HHc) 0,6× 10−3
Table 3-1.: Statistical evaluation of the DNN mitotic classifier in distinguishing different
breast cancer ODX risk groups: High ODX risk group (H), Low ODX risk group
(L) and Intermediate ODX risk group (I). Additionally, the Bloom Richardson
grading scheme was also used to define the high ODX-high grade group (HH) and
the low ODX-low grade group (LL). Note that statistically significant differences
were observed for all the 6 comparative experiments performed.
Results in Figure 3-4 and Table 3-1 reveal that the average number of mitoses for the low
ODX group is significantly different than those obtained for the high risk group. The low
ODX group obtained a mean number of 3,1 mitoses per 10 HPFs while the high ODX group
obtained a mean number of 7,2 mitoses per 10 HPFs (p = 0,1 × 10−3 with 95 % CI[−6,2,
−2,1]). When grouping the intermediate ODX group with the low ODX group, the statistical
test shows that the resultant mitoses distribution is different with respect to the high ODX
group distribution, with a mean number of 3,8 mitoses per 10 HPFs for the low/intermediate
ODX group (p = 3,6 × 10−3 with 95 % CI[−5,8, −1,15]). Besides, if the intermediate ODX
group is combined with the high ODX group, the mixed distribution results different to
the low ODX group distribution, with a mean number of 5,6 mitoses per 10 HPFs for the
intermediate/high ODX group (p = 2,3× 10−3 with 95 % CI[−4,1, −0,9]).
The analysis of the groups defined by both ODX score and BR grade also show a different
number of mitotic figures. Cases with a low ODX-low grade yielded a mean number of 2,7
mitoses per 10 HPFs while those with high ODX-high grade showed a mean number of 8,8
mitoses per 10 HPFs (p = 0,2×10−3 with 95 %CI [−9,2,−3,1]). The low ODX-low grade cases
continue to have a different number of mitoses when compared with all the remaining cases in
the dataset (those that did not have both low ODX and low grade). In this case, the average
number of mitoses per 10 HPFs for the 132 (LLc) cases was 4,74. The two distributions are
closer but still significantly different (p = 0,03 with 95 %CI [−3,98, −0,18]). Finally, when
comparing the high ODX-high grade cases with the remaining cases, a significant difference
was found. For those cases that did not have both high ODX and high grade, the mean
number of mitoses per 10HPFs was 3,8 (p = 0,6× 10−3 with 95 %CI [−7,8,−2,2).
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3.4.2. Support Vector Machine Classification Results
The distribution of mitoses per high power field was used to train a linear support vector
machine classifier to discriminate the high/low ODX BCa cases, yielding an average accuracy
of 83,19 %. Now, if one considers that the outcome of the leave one out evaluation in this
case is binary, an error of the classification gives a null accuracy for that classifier. From
the 119 different experiments, 20 resulted in a null accuracy. The confusion matrix, shown
in Table 3-2, was obtained by computing the aggregation of the confusion matrices over
each fold along the leave-one-out experiment (119 experiments in this case). The results
reveal that most of the WSIs with low ODX score are correctly classified as Low Risk.
Leveraging a SVM classifier resulted in a mean increase of approximately 15 % in the observed
accuracy (83,19 %) versus using a simple thresholding method (68,07 %). The details on how
to compute the optimal threshold are described in the Supplementary File A (See Appendix
H).
Low ODX High ODX
Classified as LR 83 8
Classified as HR 12 16
Table 3-2.: Confusion matrix for the risk stratification task using mitotic information. The
BCa cases are classified either as low risk (LR) or high risk (HR).
3.5. Concluding Remarks
In this paper we rigorously investigated the problem of automated computation of the mitotic
activity in WSI, a potential histologic image biomarker of the disease risk and aggressiveness
in ER+ breast cancers. To evaluate whether the mitotic index was associated with the risk
category determined by the Oncotype DX test, a DNN classifier was developed to identify
mitoses. The mitotic count was then evaluated in terms of its ability to distinguish the low
and high ODX risk categories as well as low and high grades. Likewise, the strategy was
able to discriminate cases with different permutations of ODX risk and grade. On a cohort
of 174 whole slide images, the automated mitotic count was significantly different for the
low ODX group when compared against the high ODX risk group, thereby demonstrating
that this quantification captures important prognostic information. This result also extends
to the BCa cases group with both low ODX and low grade. On the other hand the mitotic
detector failed to show differences between high and intermediate ODX groups.
The mitotic information extracted using the DNN achieves a sufficient level of precision and
deals with patient tissue variability. The prognostic information is captured by the support
vector machine classifier which properly distinguishes between BCa cases with both high
ODX and low ODX score.
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The lightweight DNN approach herein presented shows a similar performance to other DNN
approaches, yet the particular sampling strategy herein integrated analyzes a HPF in around
8 seconds using a conventional GPU (Nvidia Quadro K4000). Other DNN approaches in the
literature report a full HPF processing in about 8 minutes [16]. In a typical WSI, some of
the cancerous regions may have more than 500 HPFs. Consequently, the lightweight DNN
approach herein introduced is more appropriate for a diagnostic routine workflow.
The results of this study have significant clinical applicability even though the high and
intermediate risk ODX groups cannot be separated via the DNN. Patients with low ODX
have demonstrated low risk, and those patients are unlikely to derive a significant benefit
from adjuvant chemotherapy. It is less clear that it is safe to omit chemotherapy in patients
with intermediate and high risk scores, and oncologists routinely have to discuss the risks
and benefits of chemotherapy in these circumstances.
Mitotic activity of a tumor, whether measured as number of mitoses per hight power field
(as in traditional histopathologic grading), proliferation index as measured by Ki67 count by
immunohistochemistry, or as measured by gene expression by predictive/prognostic assays
such as ODX cannot be used alone to separate patients into low, intermediate or high risk
categories. Mitotic activity is an important component of these analyses but it is not the lone
determinant of the score. The fact that the mitotic activity figures from the DNN can alone
separate low versus intermediate/high is quite remarkable and has direct clinical utility. It is
possible that if this model were coupled with additional algorithms aimed at other pathologic
features in the future, the risk category could be defined further.
Future work on improving the robustness of the mitotic detector to stain variation and
including image information in the Z-axis (i.e pathologist frequently change the Z-axis of
optical microscopes to determine if a confounding nuclei is mitotic) might improve the mitosis
detector and allow for even more accurate estimation of mitotic rate. Also, future work will
involve independent validation of these findings using a separate test cohort.
4. Conclusions
This thesis has investigated the correlation of automatically extracted breast cancer biomar-
kers in histological images and the cancer risk. It is notorious that grading systems in breast
cancer (such as Bloom-Richardson system) use three histological criteria to assess the cancer
risk: tubule formation, mitotic activity and nuclear pleomorphism. Hence, a hypothesis of
this work is that automated strategies that quantify these criteria, or surrogate measures
related to them, hold enough prognostic information to discriminate high/low risk breast
cancers. This hypothesis was assessed by training a set of deep learning models to automa-
tically identify mitoses and tubular nuclei in breast cancer cases. Firstly, the computation
of a ratio between the number of tubule nuclei and the number of nuclei in the high power
fields (Tubular Formation Index - TFI) was investigated as a potential automated image
biomarker of the disease risk and aggressiveness. Secondly, the automated computation of
the mitotic activity in WSI was also studied as a potential histologic image biomarker in
ER+ breast cancers.
In the present investigation, the automated quantification of the TFI and the mitotic activity
was correlated with the risk category determined by the Oncotype DX test. For doing so,
a cohort of 174 breast cancer cases with their corresponding Oncotype DX recurrence score
and their pathological grade were used. The TFI was significantly different for the BCa
cases with low ODX-low histological grade and high ODX-high histological grade. When
comparing the high ODX-high grade group with the remaining BCa cases, the TFI was
still significantly lower. Likewise, the calculated tubule quantification measure was larger
in the BCa cases with low ODX-low grade when compared to the remaining BCa cases. In
the same cohort, the automated mitotic count was found to be significantly different for
the low ODX group when compared against the high ODX risk group, demonstrating that
automated quantification of mitoses captures important prognostic information. This result
can also be extended to the BCa cases with both low ODX and low grade. The mitotic
detector and the TFI nevertheless failed to show differences between high and intermediate
ODX groups. The mitotic information extracted using the DNN achieves a sufficient level of
precision and deals with patient tissue variability. The prognostic information is captured by
the support vector machine classifier which properly distinguishes between BCa cases with
high/low ODX score.
The computed TFI shows a slightly lower correlation with the ODX risk categories than the
automated mitosis and other automated histological features such as nuclear architecture [6].
However, information of the different features is complementary and strategies to integrate
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these features could potentially boost the accuracy of cancer risk assessment. Some previous
work has successfully combined automated features (even extracted from differently stained
samples from the same patient) and predicted the corresponding ODX risk category [5].
Therefore, fusion strategies to integrate information from different histological features (e.g.
nuclear architecture, mitotic count, tubule density) is a future research path.
The usefulness of the automated quantification of tubule formation and mitotic activity in
the clinical pathology workflows is still a pending issue to be demonstrated. These automated
quantification tools aim to reduce the inter-reader variability and to quantify the cancer risk.
These features could facilitate the streamlining and standardization of the clinical workflows.
The presented quantification algorithms were used within cancerous regions previously se-
lected by an expert pathologist. However, the automatic selection of diagnostically relevant
regions in whole slide images is an open research topic on its own, and accurate delineation
strategies have been recently introduced [19]. Future work should focus on improving the
performance of tubule and mitosis detectors, validating the presented approach on larger
test cohorts and incorporating automatic selection of region of interest.
The potential applicability of the results of this study to the clinical practice has been
demonstrated even though high and intermediate ODX risk groups could not be completely
separated. Patients with low ODX have demonstrated low risk, case in which the adjuvant
chemotherapy could be unnecessary. It is less clear how safe it could be to omit chemotherapy
in patients with intermediate and high risk scores, and oncologists routinely discuss about
chemotherapy risks and benefits in these cases. The automated quantification of histological
features (such as tubule formation or nuclear pleomorphism) might provide a clearer picture
in such cases. The mitotic activity of a tumor, that can be estimated as the number of
mitoses per high power field, or as the proliferation index by the Ki67 immuno-histochemistry
count, or as the gene expression by predictive/prognostic assays such as ODX, cannot be
used alone to determine if a breast cancer has low, intermediate or high risk of recurrence.
Mitotic activity is an important feature but not the only histological criterion. The fact that
the mitotic activity figures from the DNN can alone separate low versus intermediate/high
is quite remarkable and has clinical utility. It is possible that if this model were coupled
with additional algorithms specialized in other pathologic features, the risk category could
be defined more accurately.
The deep learning algorithms used in this study presents several limitations, that once over-
come could lead to more robust and accurate tubule/mitoses detections. The main disadvan-
tage is that generalization from a small set of annotations to the whole populations is not a
feasible task. The performance of detectors shows an important variability across H&E whole
slide images with staining variations. Future work should focus on improving the robustness
of the mitotic and tubule detectors in case of such stain variations
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